This cohort study (2024) evaluates the diagnostic accuracy of plasma phosphorylated tau 217 immunoassay in identifying Alzheimer disease pathophysiology. Results demonstrate the assay's potential as a reliable biomarker, enhancing early detection and diagnosis of Alzheimer's disease.